Tuberculosis Global Clinical Trials Review, H1, 2012

Summary

companys clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2012 provides data on the Tuberculosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tuberculosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tuberculosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by companys team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 6
Introduction 7
Tuberculosis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Tuberculosis 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Johnson & Johnson 35
Clinical Trial Overview of Johnson & Johnson 35
Aeras Global Tb Vaccine Foundation 36
Clinical Trial Overview of Aeras Global Tb Vaccine Foundation 36
Global Alliance for TB Drug Development 37
Clinical Trial Overview of Global Alliance for TB Drug Development 37
Otsuka Pharmaceutical Co., Ltd. 38
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 38
Vakzine Projekt Management GmbH 39
Clinical Trial Overview of Vakzine Projekt Management GmbH 39
AstraZeneca PLC 40
Clinical Trial Overview of AstraZeneca PLC 40
Sanofi 41
Clinical Trial Overview of Sanofi 41
EPICENTRE Biotechnologies 42
Clinical Trial Overview of EPICENTRE Biotechnologies 42
Apothecaries Private Limited 43
Clinical Trial Overview of Apothecaries Private Limited 43
Tibotec BVBA 44
Clinical Trial Overview of Tibotec BVBA 44
G.S.V.M. Medical College 45
Clinical Trial Overview of G.S.V.M. Medical College 45
RIEMSER Arzneimittel AG 46
Clinical Trial Overview of RIEMSER Arzneimittel AG 46
Archivel Farma S.L. 47
Clinical Trial Overview of Archivel Farma S.L. 47
Lupin Limited 48
Clinical Trial Overview of Lupin Limited 48
Acoustic MedSystems, Inc. 49
Clinical Trial Overview of Acoustic MedSystems, Inc. 49
Merz GmbH & Co. KGaA 50
Clinical Trial Overview of Merz GmbH & Co. KGaA 50
Novartis AG 51
Clinical Trial Overview of Novartis AG 51
Sequella, Inc. 52
Clinical Trial Overview of Sequella, Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
The National Institute of Allergy and Infectious Diseases 53
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 53
University of Oxford 56
Clinical Trial Overview of University of Oxford 56
Centers for Disease Control and Prevention 58
Clinical Trial Overview of Centers for Disease Control and Prevention 58
University of Cape Town 60
Clinical Trial Overview of University of Cape Town 60
Statens Serum Institut 61
Clinical Trial Overview of Statens Serum Institut 61
Johns Hopkins University 62
Clinical Trial Overview of Johns Hopkins University 62
French National Agency for Research on AIDS and Viral Hepatitis 63
Clinical Trial Overview of French National Agency for Research on AIDS and Viral Hepatitis 63
National Taiwan University Hospital 64
Clinical Trial Overview of National Taiwan University Hospital 64
Seoul National University Hospital 65
Clinical Trial Overview of Seoul National University Hospital 65
Tuberculosis Research Centre 66
Clinical Trial Overview of Tuberculosis Research Centre 66
Assistance Publique - Hopitaux de Paris 67
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 67
All India Institute of Medical Sciences 68
Clinical Trial Overview of All India Institute of Medical Sciences 68
Yonsei University 69
Clinical Trial Overview of Yonsei University 69
Ministry of Science & Technology 70
Clinical Trial Overview of Ministry of Science & Technology 70
Taipei Medical University WanFang Hospital 71
Clinical Trial Overview of Taipei Medical University WanFang Hospital 71
Hopitaux Universitaires de Geneve 72
Clinical Trial Overview of Hopitaux Universitaires de Geneve 72
Health Protection Agency 73
Clinical Trial Overview of Health Protection Agency 73
Radboud University 74
Clinical Trial Overview of Radboud University 74
Texas Tech University Health Sciences Center 75
Clinical Trial Overview of Texas Tech University Health Sciences Center 75
Harvard School of Public Health 76
Clinical Trial Overview of Harvard School of Public Health 76
Five Key Clinical Profiles 77
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 100
Secondary Research 100
About company 101
Contact Us 101
Disclaimer 101
Source 102

List of Tables

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2012* 13
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 14
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15
Tuberculosis Therapeutics Clinical Trials, BRIC Countries, 2012* 16
Tuberculosis Therapeutics Clinical Trials, G7 Countries, 2012* 17
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Tuberculosis Therapeutics Clinical Trials, E7 Countries, 2012* 19
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Tuberculosis Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24
Tuberculosis Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25
Tuberculosis Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 33
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 35
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Aeras Global Tb Vaccine Foundation, 2012* 36
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Global Alliance for TB Drug Development, 2012* 37
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 38
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Vakzine Projekt Management GmbH, 2012* 39
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 40
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 41
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by EPICENTRE Biotechnologies, 2012* 42
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Apothecaries Private Limited, 2012* 43
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tibotec BVBA, 2012* 44
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by G.S.V.M. Medical College, 2012* 45
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by RIEMSER Arzneimittel AG, 2012* 46
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Archivel Farma S.L., 2012* 47
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Lupin Limited, 2012* 48
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Acoustic MedSystems, Inc., 2012* 49
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merz GmbH & Co. KGaA, 2012* 50
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 51
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sequella, Inc., 2012* 52
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2012* 53
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2012* 56
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Centers for Disease Control and Prevention, 2012* 58
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2012* 60
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Statens Serum Institut, 2012* 61
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2012* 62
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by French National Agency for Research on AIDS and Viral Hepatitis, 2012* 63
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012* 64
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012* 65
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tuberculosis Research Centre, 2012* 66
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 67
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2012* 68
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yonsei University, 2012* 69
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Ministry of Science & Technology, 2012* 70
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taipei Medical University WanFang Hospital, 2012* 71
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopitaux Universitaires de Geneve, 2012* 72
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Health Protection Agency, 2012* 73
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012* 74
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Texas Tech University Health Sciences Center, 2012* 75
Tuberculosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Harvard School of Public Health, 2012* 76

List of Figures

Tuberculosis Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8
Tuberculosis Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10
Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11
Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12
Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13
Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 14
Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15
Tuberculosis Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16
Tuberculosis Therapeutics Clinical Trials, G7 Countries (%), 2012* 17
Tuberculosis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18
Tuberculosis Therapeutics Clinical Trials, E7 Countries (%), 2012* 19
Tuberculosis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20
Tuberculosis Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21
Tuberculosis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22
Tuberculosis Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23
Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 27
Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 28
Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 30
Tuberculosis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 32
company Methodology 100